Table 2. Sites of infection for 105 reported anti–TNF-α therapy–associated cases of NTM disease, US Food and Drug Administration MedWatch database, 1999–2006*.

Site	No. (%) cases
Pulmonary region	59 (56)
Skin or soft tissue	27 (26)
Bone or joint	10 (9)
Disseminated	8 (8)
Eye	1 (1)

*TNF-α, tumor necrosis factor-α; NTM, nontuberculous mycobacteria.